MOA of Alpha-Adrenergic Blockers

Mechanism of Action of Alpha-Adrenergic Blockers

by

Introduction

Alpha-adrenergic blockers, also called alpha-blockers, are a class of drugs that antagonize the effects of catecholamines (epinephrine and norepinephrine) at alpha-adrenergic receptors. Mechanism of Action of Alpha-Adrenergic Blockers involves inhibition of alpha-1 and/or alpha-2 receptors, resulting in vasodilation, decreased peripheral vascular resistance, and reduced blood pressure. These drugs are commonly used in the management of hypertension, benign prostatic hyperplasia (BPH), and certain vascular disorders.

Mechanism of action of Alpha-Blockers
Alpha-blocker pharmacology
Mechanism of Action of Alpha-Adrenergic Blockers
Pharmacology and clinical effects of Alpha-Adrenergic Blockers

Mechanism of Action (Step-wise)

  1. Blockade of Alpha-Adrenergic Receptors
    • Alpha-blockers competitively inhibit the binding of norepinephrine to alpha-adrenergic receptors located on vascular smooth muscle.
    • Depending on selectivity, they may block alpha-1, alpha-2, or both receptor types.
  2. Vascular Effects (Alpha-1 Blockade)
    • Alpha-1 receptors mediate vasoconstriction via increased intracellular calcium.
    • Blocking these receptors leads to vascular smooth muscle relaxation, resulting in vasodilation and decreased systemic vascular resistance.
    • This reduces blood pressure and afterload on the heart.
  3. Effects on Prostate and Bladder Neck
    • In the prostate and bladder neck, alpha-1A receptors mediate smooth muscle tone.
    • Alpha-1A blockers (e.g., tamsulosin) relax these muscles, improving urine flow and reducing BPH symptoms.
  4. Reflex Tachycardia (Alpha-2 Blockade)
    • Non-selective alpha blockers (e.g., phentolamine) also block alpha-2 receptors presynaptically, leading to increased norepinephrine release.
    • This can cause reflex tachycardia and enhanced cardiac stimulation.
  5. Overall Effect
    • Alpha-1 Selective Blockers: Vasodilation → ↓ Blood Pressure → ↓ Afterload.
    • Non-Selective Blockers: Vasodilation + Reflex tachycardia.
    • Prostate-Selective Blockers: Relaxation of bladder outlet → Improved urine flow.
Stepwise mechanism of action of Alpha-Adrenergic Blockers
Alpha-Blocker MOA Flowchart

Pharmacokinetics

  • Absorption: Well absorbed orally; food may delay absorption but reduce first-dose hypotension.
  • Distribution: Widely distributed; highly protein bound.
  • Metabolism: Mainly hepatic via CYP enzymes.
  • Excretion: Renal and biliary routes.
  • Half-life: Varies—short (phentolamine) to long (doxazosin).

Clinical Uses

  • Hypertension: Doxazosin, Prazosin, Terazosin.
  • Benign prostatic hyperplasia (BPH): Tamsulosin, Alfuzosin, Silodosin.
  • Pheochromocytoma: Phenoxybenzamine, Phentolamine (pre-operative control of blood pressure).
  • Raynaud’s disease and scleroderma-related vasospasm.

Adverse Effects

  • Common: Dizziness, postural hypotension, fatigue, nasal congestion.
  • Less common: Headache, reflex tachycardia, peripheral edema.
  • Serious: Syncope (first-dose phenomenon), priapism (rare), arrhythmias (with non-selective agents).
  • Contraindications: Severe hepatic impairment, hypotension, or heart failure (use cautiously).

Comparative Analysis

FeatureAlpha-1 Blockers (e.g., Prazosin)Non-Selective Blockers (e.g., Phentolamine)Alpha-1A Blockers (e.g., Tamsulosin)
Primary actionVasodilationVasodilation + reflex tachycardiaRelaxation of prostate & bladder neck
Effect on BPDecreaseDecrease with reflex ↑ HRMinimal systemic effect
Used forHypertension, BPHPheochromocytomaBPH only
First-dose hypotensionCommonModerateRare
CNS effectsMild dizzinessSignificantMinimal

MCQs

1. Alpha-adrenergic blockers act by:
a) Stimulating alpha receptors
b) Blocking alpha receptors
c) Activating beta receptors
d) Inhibiting acetylcholine release

Answer: b) Blocking alpha receptors

2. Which receptor subtype mediates vascular smooth muscle contraction?
a) Alpha-1
b) Alpha-2
c) Beta-1
d) Beta-2

Answer: a) Alpha-1

3. Which of the following is a selective alpha-1 blocker?
a) Phentolamine
b) Phenoxybenzamine
c) Prazosin
d) Yohimbine

Answer: c) Prazosin

4. Tamsulosin acts primarily on:
a) Alpha-1B receptors in arteries
b) Alpha-1A receptors in prostate
c) Alpha-2 receptors in CNS
d) Beta-2 receptors in lungs

Answer: b) Alpha-1A receptors in prostate

5. Which adverse effect is most characteristic of alpha blockers?
a) Hypertension
b) Postural hypotension
c) Bradycardia
d) Bronchospasm

Answer: b) Postural hypotension

6. Reflex tachycardia occurs mainly with:
a) Alpha-1 blockers
b) Alpha-2 blockers
c) Non-selective alpha blockers
d) Beta blockers

Answer: c) Non-selective alpha blockers

7. Phenoxybenzamine differs from phentolamine because it:
a) Is reversible
b) Is irreversible
c) Acts only on alpha-2 receptors
d) Has no effect on BP

Answer: b) Is irreversible

8. Alpha blockers are used in which condition?
a) Asthma
b) Hypertension
c) Hypotension
d) Parkinsonism

Answer: b) Hypertension

9. Which is a long-acting alpha-1 blocker?
a) Doxazosin
b) Prazosin
c) Phentolamine
d) Yohimbine

Answer: a) Doxazosin

10. The “first-dose phenomenon” is seen with:
a) Beta blockers
b) Alpha blockers (especially prazosin)
c) Calcium channel blockers
d) ACE inhibitors

Answer: b) Alpha blockers (especially prazosin)

FAQs

Q1. How do alpha blockers lower blood pressure?
They block alpha-1 receptors in blood vessels, leading to vasodilation and reduced peripheral resistance.

Q2. Why is prazosin given at bedtime initially?
To prevent first-dose postural hypotension and fainting.

Q3. What is the difference between selective and non-selective alpha blockers?
Selective alpha-1 blockers act only on vascular receptors, while non-selective agents block both alpha-1 and alpha-2, causing reflex tachycardia.

Q4. Can alpha blockers be used for prostate enlargement?
Yes, alpha-1A blockers like tamsulosin improve urine flow in benign prostatic hyperplasia.

Q5. Why are alpha blockers used in pheochromocytoma?
They control blood pressure by blocking excessive catecholamine-induced vasoconstriction.

Q6. What causes the “first-dose effect”?
Sudden vasodilation after the first dose leads to transient hypotension and syncope.

References

  • Goodman & Gilman’s The Pharmacological Basis of Therapeutics
  • Katzung’s Basic and Clinical Pharmacology
  • Harrison’s Principles of Internal Medicine
  • Clinical Hypertension Guidelines (JNC-8, ESC/ESH)

Leave a Comment